A number of war epidemic "weapons" appeared in Science and Technology Week
5G smart factories, recombinant new coronavirus vaccines (adenovirus vectors), stem cell drugs, rapid detection kits for new coronaviruses, the second comprehensive scientific investigation on the Qinghai-Tibet Plateau "Jimu No. 1" floating vessel, "Haidou No. 1" Haishen's autonomous remote-controlled underwater robots... On August 29, the week-long National Science and Technology Week came to an end, with many high-tech products unveiled. Focusing on the theme of “a powerful country in the fight against epidemics in science and technology”, various online and offline activities were held in various places to provide a richer and more convenient stage for the public to understand, experience, and share the achievements of scientific and technological innovation, and to gather a broader scientific and technological consensus.
Science and technology war epidemic attracts attention
This year marks the 20th anniversary of Science and Technology Week. In Beijing, the main venue, row upon row of war epidemic "weapons" attracted the attention of many visitors.
A wearable smart thermometer, a portable bioaerosol sampler, a portable cell sorter, an improved and comfortable high-collection sampler, a new type of transfer cabin, a cell and virus science bibliography that integrates body temperature big data and artificial intelligence analysis system, fully It shows the major achievements made by our country's scientific and technological workers after hard work.
According to Li Hao, an associate researcher at the Institute of Microbiology and Epidemiology of the Military Medical Academy, the CRISPR new coronavirus nucleic acid test strip developed by the institute is simple to operate and does not require professional testing equipment. It can be used by primary hospitals and even families and can be tested within 60 minutes. result.
The research and development personnel of a new coronavirus inactivated vaccine told reporters that the vaccine has passed two phases of clinical trials, and the third phase of trials is underway. When the reporter asked about the safety of the vaccine and whether the virus mutation in autumn and winter would affect the immune effect of the vaccine, the researcher responded that the new coronavirus has not mutated significantly so far and is not expected to have much impact on the vaccine effect. According to him, there is a certain cycle of vaccine development and production. If the virus mutates, it is unlikely that a new vaccine will be produced immediately. It will take some time to adjust the vaccine in time to deal with the new strain. During this period, the public should still pay attention to maintaining good hygiene habits and take personal protection to deal with the epidemic.
In addition to the “weapon” of the war against the epidemic, as a special content, this technology week also launched the “Cloud Showroom” for the first time, focusing on the content of the war against the epidemic, innovation achievements, science and technology to benefit the people, and services for poverty alleviation.
Innovation and development gather a broader social consensus
In the context of the normalization of epidemic prevention and control, the content and format of this year's Science and Technology Week is very different from previous years. And technological innovation has further become a hot topic that has attracted much attention from the society.
Since the outbreak of the new crown pneumonia epidemic, science and technology have played an important supporting role in defeating the epidemic, and technological innovation has also played an important supporting role in the country's economic and social development. At present, my country's new technologies, new equipment, and new products in artificial intelligence, 5G technology, and biotechnology are accelerating the emergence of new technologies, and the concept of innovative development has increasingly become a broad consensus among all sectors of society.
According to Wang Fuli, an engineer from the Shenyang Institute of Automation, Chinese Academy of Sciences, the "Haidou No. 1" unmanned submersible developed by the institute has realized my country's first 10,000-meter deep diving operation and filled the gap in my country's operational full-sea deep underwater robots. "As a milestone in the field of my country's marine technology, it marks the entry of my country's unmanned submersibles into a new era of full-sea deep exploration and operation." Wang Fuli said.
In a smart factory in Beijing Economic and Technological Development Zone, the shuttle robots are driven by 5G to operate accurately. According to Liang Sheng, director of the Beijing Economic and Technological Development Zone Management Committee, the factory production line uses technologies such as robots and big data on a large scale. Compared with the traditional factory, it has increased by more than 60%.
"We have built a number of smart factories. In the past five years, the industrial output value of the above-scale industries in the Economic Development Zone has increased from 180 billion yuan to 420 billion yuan, but the front-line operators have dropped from 300,000 to 270,000. Will actively participate in the formulation of intelligent manufacturing standards, and contribute to accelerating the construction of a manufacturing power." Liang Sheng said.
Looking forward to more scientific and technological innovations to serve the epidemic
In the Beijing Yunshang Technology Exhibition Hall, innovations such as vaccines, diagnostic reagents, drug development and artificial intelligence temperature measurement equipment, intelligent dry mist elimination robots, new coronary pneumonia CT imaging artificial intelligence-assisted diagnostic products, and reusable medical protective clothing are presented one by one , Which fully demonstrated Beijing’s important achievements in scientific and technological prevention and control of the epidemic.
The reporter learned that during the National Science and Technology Week, the public participates in activities in various forms. Speeding up the development of vaccines and other drugs, exploring more scientific and efficient prevention and control measures, continuing to monitor the virus, and real-time accurate prevention and control of the epidemic. These suggestions are full of the public's eager anticipation for the scientific and technological war on the epidemic and scientific prevention and control.
Hao Jie, associate researcher of the Institute of Stem Cell and Regenerative Medicine Innovation of the Chinese Academy of Sciences and director of the National Stem Cell Resource Bank, introduced to reporters a stem cell drug for the treatment of new coronary pneumonia by the research team of the Institute. This drug obtained the clinical trial approval of the State Food and Drug Administration in February this year, becoming the first stem cell drug to enter the clinic in the global anti-epidemic, with complete independent intellectual property rights.
"Innovation Research Institute has been committed to the development of stem cell drugs for the treatment of major diseases for more than 10 years. After the outbreak of the new crown pneumonia, we urgently organized a research team to develop a stem cell drug for the treatment of cytokine storms and for the treatment of critical and critical illnesses of new coronary pneumonia. "Hao Jie said, "China's stem cell treatment of new coronary pneumonia has made good progress and is currently the only treatment for critically ill treatment."
Hao Jie introduced that in addition to the development of stem cell drugs, the Stem Cell Innovation Institute has also developed a new generation of detection technology based on the latest gene editing technology, which technically has a broader application prospect than nucleic acid detection on the market. "This kit is completely based on our intellectual property technology research and development, without expensive equipment, nucleic acid test results can be obtained within 30 minutes."
(Our reporter Zhang Yaxiong)